Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).
An Update on Heart Failure in Primary Care
Allergen Introduction – Practical Tips for GPs
Falls Prevention – A Practical, Evidence-Based Update on What Really Works
The New Dementia Test and How they Fit Into the Assessment and Management of the Patient with Cognitive Concerns
expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis